Filter news by date News Tags - Any -News storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2024202320222021202020192018201720162015201420132012201120102009200820072006 Apply 7 . 27 . 2021 Press release Sol-Gel Technologies Announces FDA Approval of TWYNEO® 6 . 29 . 2021 Press release Galderma receives FDA approval for Restylane® Contour for cheek augmentation and correction of midface contour deficiencies 6 . 28 . 2021 Press release Sol-Gel Technologies and Galderma announce exclusive licenses for the commercialization of EPSOLAY® and TWYNEO® in the United States 6 . 11 . 2021 Press release Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe 5 . 19 . 2021 Press release How Galderma's Environmental, Social and corporate Governance approach guides its roadmap for sustainable growth 5 . 11 . 2021 Press release Galderma launches CETAPHIL® line for sensitive skin and a new DAYLONG® sun protection product in Switzerland 5 . 6 . 2021 Press release New study reveals the impact of ‘hidden acne’ on quality of life 5 . 4 . 2021 Press release Galderma launches new Multichannel Medical Education platform: Inaugural webinar series on the impact of mask wearing on skin diseases 5 . 3 . 2021 Press release Cetaphil® Champions Sun Protection Awareness and Education with Dermatologist-led Digital Campaign 4 . 28 . 2021 Press release Galderma acts on workplace health and safety 4 . 21 . 2021 Press release #RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month 4 . 8 . 2021 Press release Galderma announces publication of phase 2b trial results demonstrating the rapid and long-lasting benefits of nemolizumab in clinical trial subjects with uncontrolled atopic dermatitis Pagination Previous page Previous Page Next page Next Page